Letters to the Editor

TNF-α signaling drives myeloid skewing and clonal expansion of stem and progenitors in RUNX1-familial platelet disorder

The Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA; Division of Oncological Sciences, Oregon Health and Science University, Portland, OR, USA; Department of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, OR, USA; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR
The Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA; Division of Oncological Sciences, Oregon Health and Science University, Portland, OR, USA; Department of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, OR, USA; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR
The Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA; Division of Oncological Sciences, Oregon Health and Science University, Portland, OR, USA; Department of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, OR, USA; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR
The Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA; Division of Oncological Sciences, Oregon Health and Science University, Portland, OR, USA; Department of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, OR, USA; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR
Cellular Therapy Laboratory, Oregon Health and Science University, Portland, OR
Department of Orthopedics and Rehabilitation, Oregon Health and Science University, Portland, OR
Department of Orthopedics and Rehabilitation, Oregon Health and Science University, Portland, OR
Oncogenesis and Development Section, Division of Intramural Research, National Human Genome Research Institute, NIH, Bethesda, MD
Oncogenesis and Development Section, Division of Intramural Research, National Human Genome Research Institute, NIH, Bethesda, MD
The Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA; Division of Oncological Sciences, Oregon Health and Science University, Portland, OR, USA; Department of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, OR, USA; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR
Haematologica Early view Nov 6, 2025 https://doi.org/10.3324/haematol.2025.288410